E-LIB Suche - Ergebnisse für: Scherma, M.

1

An overall view of the most common experimental models for ..:

Dedoni, S. ; Scherma, M. ; Camoglio, C....
Neurobiology of Disease. 184 (2023) - p. 106230 , 2023

Link: https://doi.org/10.1016/..

2

Exploring the association between brain-derived neurotrophi..:

Isayeva, U. ; Manchia, M. ; Primavera, D....
European Psychiatry. 65 (2022) S1 - p. S154-S154 , 2022

Link: https://doi.org/10.1192/..

3

P.049 The impact of depot and long acting injectable antips..:

Manchia, M. ; Primavera, D. ; Deriu, L....
European Neuropsychopharmacology. 29 (2019) - p. S54-S55 , 2019

Link: https://doi.org/10.1016/..

4

Clinical and genetic determinants of serum brain-derived ne..:

Manchia, M. ; Deriu, L. ; Tusconi, M....
European Neuropsychopharmacology. 29 (2019) - p. S133-S134 , 2019

Link: https://doi.org/10.1016/..

5

The longitudinal trajectory of serum brain-derived neurotro..:

Manchia, M. ; Primavera, D. ; Deriu, L....
European Neuropsychopharmacology. 27 (2017) - p. S913 , 2017

Link: https://doi.org/10.1016/..

6

P.2.008 Effect of acute and chronic administration of a new..:

Zanda, M.T. ; Antinori, S. ; Mutti, A....
European Neuropsychopharmacology. 26 (2016) - p. S30-S31 , 2016

Link: https://doi.org/10.1016/..

7

P.2.021 The endocannabinoid system: possible new pharmacolo..:

Collu, R. ; Scherma, M. ; Satta, V....
European Neuropsychopharmacology. 26 (2016) - p. S41-S42 , 2016

Link: https://doi.org/10.1016/..

8

BDNF serum levels as a biomarker of depressive symptoms in ..:

Primavera, D. ; Manchia, M. ; Tusconi, M....
European Neuropsychopharmacology. 26 (2016) - p. S365-S366 , 2016

Link: https://doi.org/10.1016/..

9

The endocannabinoid system: possible new pharmacological ta..:

Collu, R. ; Scherma, M. ; Satta, V....
European Neuropsychopharmacology. 26 (2016) - p. S129 , 2016

Link: https://doi.org/10.1016/..

10

Pharmacological modulation of the endocannabinoid signallin..:

Scherma, M ; Fattore, L ; Satta, V...
British Journal of Pharmacology. 169 (2013) 4 - p. 820-833 , 2013

Link: https://doi.org/10.1111/..

11

P.4.b.008 Effect of cannabinoid CB1 receptor agonist WIN 55..:

Fadda, P. ; Scherma, M. ; Salis, P....
European Neuropsychopharmacology. 16 (2006) - p. S464 , 2006

Link: https://doi.org/10.1016/..

12

Endocannabinoid system and opioid addiction: Behavioural as..:

FATTORE, L ; DEIANA, S ; SPANO, S...
Pharmacology Biochemistry and Behavior. 81 (2005) 2 - p. 343-359 , 2005

Link: https://doi.org/10.1016/..

13

The effects of ω−6 and ω−3 fatty-acids on early stages of m..:

Scherma, M.E. ; Madzzuduli, G. ; Silva, R.A....
Prostaglandins, Leukotrienes and Essential Fatty Acids. 125 (2017) - p. 48-55 , 2017

Link: https://doi.org/10.1016/..

14

Identifying Neurobiological Markers in Obsessive–Compulsive..:

Paribello P ; Carpiniello B ; Murgia R...
info:eu-repo/semantics/altIdentifier/wos/WOS:001016960000001. , 2023

Link: https://hdl.handle.net/1..

15

Anaplastic Lymphoma Kinase Receptor: Possible Involvement i..:

Dedoni S ; Scherma M ; Camoglio C...
info:eu-repo/semantics/altIdentifier/wos/WOS:000987586900001. , 2023

Link: https://hdl.handle.net/1..